In vitro

Global In Vitro Toxicity Testing (2020 to 2025) - Increasing Number of Toxicology Databases Presents Opportunities - ResearchAndMarkets.com

Retrieved on: 
Thursday, September 10, 2020
Professional services, Consulting, Animal testing, Toxicology, In vitro, Medical specialties, Health, Branches of science

Based on the product and service, the in vitro toxicology testing market is segmented into consumables, assays, equipment, software, and services.

Key Points: 
  • Based on the product and service, the in vitro toxicology testing market is segmented into consumables, assays, equipment, software, and services.
  • The software segment is projected to witness the highest growth in the in vitro toxicology testing market during the forecast period.
  • The ADME segment accounted for the largest share of the in vitro toxicity testing market in 2018.
  • Europe is expected to hold the largest share for players operating in the in vitro toxicology testing market.

Four Noteworthy Driving Factors in the In-Vitro Diagnostics Market | Infiniti’s Market Research Experts Discuss the Optimal Approach

Retrieved on: 
Monday, September 7, 2020
Health, Pharmaceutical, Alternatives to animal testing, In vitro

Infinitis healthcare market research services enable companies in the in-vitro diagnostics market, and other segments of the healthcare industry to not only know about the trends, driving factors, and opportunities in the market but also enables them to capitalize on the same efficiently.

Key Points: 
  • Infinitis healthcare market research services enable companies in the in-vitro diagnostics market, and other segments of the healthcare industry to not only know about the trends, driving factors, and opportunities in the market but also enables them to capitalize on the same efficiently.
  • View the full release here: https://www.businesswire.com/news/home/20200907005247/en/
    Four Noteworthy Driving Factors in the In-Vitro Diagnostics Market (Graphic: Business Wire)
    To leverage Infinitis expertise in offering healthcare market research services, and compete in the rapidly evolving and innovative in-vitro diagnostics market, request a free proposal .
  • However, the first step to achieving a greater market share is having a comprehensive understanding of the drivers influencing growth in the in-vitro diagnostics market, says an in-vitro diagnostics market expert at Infiniti Research.
  • Therefore, Infinitis healthcare market research experts discuss the most noteworthy market growth drivers in their recent article and highlight how market research services enable companies to capitalize on them.

Japan $4.43 Bn In-Vitro Diagnostics (IVD) Market Outlook, 2020-2026 - ResearchAndMarkets.com

Retrieved on: 
Thursday, September 3, 2020
Health, Other Health, IVD, In vitro, Medical tests, Biology, Natural sciences, Life sciences, Molecular diagnostics

The "Japan In-Vitro Diagnostics (IVD) Market, by Diagnostics, Companies, Reimbursements, Porter's Model, Growth Drivers, Opportunities Challenges" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Japan In-Vitro Diagnostics (IVD) Market, by Diagnostics, Companies, Reimbursements, Porter's Model, Growth Drivers, Opportunities Challenges" report has been added to ResearchAndMarkets.com's offering.
  • In recent years, several developments have happened in the field of In-vitro diagnostics like conventional diagnostics to new generation gene diagnostics.
  • This report provides a complete analysis of Japan In Vitro Diagnostics (IVD) Market.
  • In this report, we have provided a complete analysis of 11 segments of the Japan In-vitro Diagnostic market.

Progenity to Participate in Two Upcoming Investor Conferences

Retrieved on: 
Wednesday, September 2, 2020
Alternatives to animal testing, Evidence-based medicine, Precision medicine, Systems biology, In vitro, Wells Fargo, Branches of biology, Biology, Natural sciences

ET / 9:15 a.m. PT on September 9, 2020; and

Key Points: 
  • ET / 9:15 a.m. PT on September 9, 2020; and
    An analyst-led group meeting at the 2020 Wells Fargo Virtual Healthcare Conference at 12:40 p.m.
  • Progenity, Inc. is a biotechnology company with an established track record of success in developing and commercializing molecular testing products, as well as innovating in the field of precision medicine.
  • Progenity provides in vitro molecular tests designed to improve lives by providing actionable information that helps guide patients and physicians in making medical decisions during key life stages.
  • For additional information about Progenity, please visit the companys website at www.progenity.com .

FDA allows Sound Pharmaceuticals to test SPI-1005 as a novel treatment for COVID-19

Retrieved on: 
Monday, August 31, 2020
Ebselen, National Institute of Allergy and Infectious Diseases, Spi-1 (PU.1) 5′ UTR regulatory element, In vitro, Coronavirus disease, Chemistry, Biology, Articles

SEATTLE, Aug. 31, 2020 /PRNewswire/ -- Sound Pharmaceuticals, Inc. (SPI) is pleased to announce that the FDA has allowed two Phase 2 studies to begin testing ebselen (SPI-1005) in COVID-19 patients.

Key Points: 
  • SEATTLE, Aug. 31, 2020 /PRNewswire/ -- Sound Pharmaceuticals, Inc. (SPI) is pleased to announce that the FDA has allowed two Phase 2 studies to begin testing ebselen (SPI-1005) in COVID-19 patients.
  • SPI is developing SPI-1005, a novel anti-inflammatory drug which was recently shown to inhibit nCoV2 activity and viral replication.
  • Separately, SPI will be utilizing the non-clinical and pre-clinical services program offered by the National Institute of Allergy and Infectious Diseases (NIAID).
  • This will involve the expanded testing of ebselen both in vitro and in vivo, including a unique live animal model of COVID-19 transmission.

In Vitro Toxicology Testing Market worth $14.9 billion by 2025 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Friday, August 28, 2020
Alternatives to animal testing, In vitro, Toxicology, Natural sciences

The large share of this segment can be attributed to the increasing demand for high-quality reagents and the repeated use of media and reagents in in vitro toxicology studies.

Key Points: 
  • The large share of this segment can be attributed to the increasing demand for high-quality reagents and the repeated use of media and reagents in in vitro toxicology studies.
  • Based on the technologies used in the in vitro toxicology testing, the cell culture technologies segment is expected to account for the largest share of the in vitro toxicology testing market
    The cell culture technologies segment is estimated to account for the largest market share in 2018.
  • Get 10% Customization on this Research Report:
    The APAC market is projected to register the highest growth during the forecast period.
  • Get Special Pricing on Bundle Reports:
    In Vitro Diagnostics Market by Product (Instruments, Reagents), Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Hematology, Urinalysis), Application (Diabetes, Oncology, Cardiology, Nephrology) - Forecast to 2023

In Vitro Toxicology Testing Market worth $14.9 billion by 2025 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Friday, August 28, 2020
Alternatives to animal testing, In vitro, Toxicology, Natural sciences

The large share of this segment can be attributed to the increasing demand for high-quality reagents and the repeated use of media and reagents in in vitro toxicology studies.

Key Points: 
  • The large share of this segment can be attributed to the increasing demand for high-quality reagents and the repeated use of media and reagents in in vitro toxicology studies.
  • Based on the technologies used in the in vitro toxicology testing, the cell culture technologies segment is expected to account for the largest share of the in vitro toxicology testing market
    The cell culture technologies segment is estimated to account for the largest market share in 2018.
  • Get 10% Customization on this Research Report:
    The APAC market is projected to register the highest growth during the forecast period.
  • Get Special Pricing on Bundle Reports:
    In Vitro Diagnostics Market by Product (Instruments, Reagents), Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Hematology, Urinalysis), Application (Diabetes, Oncology, Cardiology, Nephrology) - Forecast to 2023

XYLYX BIO releases highly physiologic 2D substrates for improved antifibrotic drug discovery

Retrieved on: 
Wednesday, August 26, 2020
Alternatives to animal testing, In vitro

Existing models do not replicate the complexity of human disease, impeding the translation of research to patients and contributing to numerous and expensive drug failures.

Key Points: 
  • Existing models do not replicate the complexity of human disease, impeding the translation of research to patients and contributing to numerous and expensive drug failures.
  • Importantly, NativeCoat substrates for antifibrotic drug discovery are the only substrates on the market capable of bringing clinical context into the in vitro setting.
  • "Antifibrotic drug discovery lacks predictive and truly translatable biological models that can reliably generate early efficacy insights that accurately inform the potential clinical performance of a drug," stated John O'Neill, CSO at Xylyx Bio.
  • Xylyx Bio provides its specialized biomaterials and corresponding data packages to leading scientists globally in academia, biotech, and pharma.

COVID-19 Fuelling Notable Growth in In-Vitro Diagnostics Market, Creating Novel Growth Opportunities for Players: TMR Study

Retrieved on: 
Wednesday, August 19, 2020
Market research, In vitro, Medical tests, Natural sciences

A slew of factors such as positive transformations in medical and healthcare industries are supporting the projected market growth over the stated period.

Key Points: 
  • A slew of factors such as positive transformations in medical and healthcare industries are supporting the projected market growth over the stated period.
  • As per Transparency Market Research, "Development of state-of-the-art diagnostics facilities is a major growth factor in the global in-vitro diagnostics market.
  • Key Findings of Global In-vitro Diagnostics Market Study:
    Owing to increase in demand for better diagnostics in oncology, the relevant application segment will drive demand for in-vitro diagnostics in a major way
    North American region will account for a large share of the global in-vitro diagnostics market over the assessment period.
  • Innovation holds a prominent place in overall growth strategy for most notable players.

COVID-19 Fuelling Notable Growth in In-Vitro Diagnostics Market, Creating Novel Growth Opportunities for Players: TMR Study

Retrieved on: 
Wednesday, August 19, 2020
Market research, In vitro, Medical tests, Natural sciences

A slew of factors such as positive transformations in medical and healthcare industries are supporting the projected market growth over the stated period.

Key Points: 
  • A slew of factors such as positive transformations in medical and healthcare industries are supporting the projected market growth over the stated period.
  • As per Transparency Market Research, "Development of state-of-the-art diagnostics facilities is a major growth factor in the global in-vitro diagnostics market.
  • Key Findings of Global In-vitro Diagnostics Market Study:
    Owing to increase in demand for better diagnostics in oncology, the relevant application segment will drive demand for in-vitro diagnostics in a major way
    North American region will account for a large share of the global in-vitro diagnostics market over the assessment period.
  • Innovation holds a prominent place in overall growth strategy for most notable players.